Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Sepsis × Colistin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 2 Sepsis 1 Neutropenia 1 Hematological Infection 1 Gram-Negative Bacterial Infections 1 Colorectal Neoplasms 1 Anastomotic Leak 1

Interventions

Anti-Bacterial Agents 2 ziprasidone 1 telavancin 1 soybean oil, phospholipid emulsion 1 drotrecogin alfa activated 1 Zolpidem 1 Warfarin 1 Vecuronium Bromide 1 Vancomycin 1 Trimethoprim, Sulfamethoxazole Drug Combination 1 Tranexamic Acid 1 Tobramycin 1 Spironolactone 1 Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization 1 Simvastatin 1 Sevelamer 1 Saline Solution 1 Rocuronium 1 Povidone-Iodine 1 Piperacillin, Tazobactam Drug Combination 1 Pentobarbital 1 Oxycodone 1 Nifedipine 1 Nafcillin 1 Multiplex Polymerase Chain Reaction 1 Molindone 1 Methylprednisolone 1 Methods 1 Meropenem 1 Massage 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01931592 2017-05-08

CLEAR

University of Cologne

Phase 2/3 Terminated

Neoplasms, Neutropenia, Sepsis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡